Pending and Planned Projects
Mitigation of symptoms for PTSD, with or without mild TBI
This project will be a single site, open label feasibility trial at evaluating the use of HIRREM as an adjunct for 10 military service members diagnosed with PTSD, with or without mild TBI, who meet protocol exclusion criteria for current medications. Implementation awaits arrival of funding.
HIRREM for persisting post-concussion symptoms in athletes
Organized in collaboration with the Sports Medicine Section in the Department of Family and Community Medicine at Wake Forest School of Medicine, this project will be a single site, open label, randomized, wait list control, crossover trial to evaluate the effects of HIRREM plus usual care, compared to continuation of usual care alone, for athletes with concussion who experience symptoms persisting longer than 4 weeks following the TBI/concussion. This study will assess the effect of HIRREM on overall post-concussion symptoms, with a focus on headache, sleep, depression, clarity/focus, and balance.
HIRREM for hot flashes
This project will be designed as a single site, randomized, single blind, placebo-controlled research trial to evaluate the effect of HIRREM on frequency and severity of hot flashes in post-menopausal women.
HIRREM for insomnia in civilian PTSD
This project will be designed as a single site, open label, randomized, wait list control, crossover research trial to evaluate the effect of HIRREM plus usual care compared to continuation of usual care alone for symptoms of insomnia associated with PTSD in civilians.